Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIA2 | P42262 | 1/20 | 0.35 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.35 |
| ▸ | USP30 | Q70CQ3 | 5/20 | 0.33 |
| ▸ | BRD4 | O60885 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.32 |
| ▸ | BRD2 | P25440 | 1/20 | 0.31 |
| ▸ | BRD3 | Q15059 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | SRD5A1 | P18405 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17952198 | 0.90 | GRIA2 (0.35) | GRIA2GRIA4USP30BRD4ALDH1A1 | |
| SCHEMBL17952318 | 0.82 | ALDH1A1 (0.37) | BRD4ALDH1A1KDM4EGAAGLA | |
| SCHEMBL17952253 | 0.82 | GABRA1 (0.37) | GRIA2GRIA4BRD4EGLN1BRD2 | |
| SCHEMBL17952273 | 0.82 | NPSR1 (0.38) | ALDH1A1KDM4EHPGDLMNA | |
| SCHEMBL21361140 | 0.82 | ALDH1A1 (0.38) | ALDH1A1KDM4EGAAHPGDLMNA | |
| SCHEMBL17952274 | 0.81 | ALDH1A1 (0.36) | GRIA2GRIA4ALDH1A1KDM4EGAA | |
| SCHEMBL17952196 | 0.79 | SMN1; SMN2 (0.36) | USP30ALDH1A1KDM4EGAAGLA | |
| SCHEMBL17947663 | 0.79 | SMN1; SMN2 (0.36) | USP30BRD4ALDH1A1KDM4EGAA | |
| SCHEMBL12393019 | 0.79 | BRD4 (0.37) | BRD4ALDH1A1KDM4EGAAEGLN1 | |
| SCHEMBL17952492 | 0.78 | SMN1; SMN2 (0.36) | GRIA2GRIA4ALDH1A1KDM4EGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10418569-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2019-09-17 | — | — | US | disclosed |
| US-20160218303-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2016-07-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10418569-B2 | Organic electroluminescent materials and devices | OCIAD2, OCIAD1, OSBP2 | GRIA2 2029/4885GRIA4 3079/4885USP30 4777/4885 |
| US-20160218303-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OCIAD1, OSBP2 | GRIA2 2029/4885GRIA4 3079/4885USP30 4777/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.